Department of Radiation Oncology, National University Cancer Institute, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore.
BMC Cancer. 2020 Mar 6;20(1):193. doi: 10.1186/s12885-020-6664-3.
To determine the optimal timing of the first Magnetic Resonance Imaging (MRI) scan after curative-intent radiotherapy (RT) for nasopharyngeal carcinoma (NPC), and evaluate the role of MRI in surveillance for locoregional recurrence (LRR).
Patients with non-metastatic NPC treated radically who had at least one post-treatment MRI (ptMRI) done were included for analysis. ptMRI reports were retrospectively reviewed and categorised as complete response (CR), partial response/residual disease (PR) or indeterminate (ID). Patients with LRR were assessed to determine if initial detection was by MRI or clinical means. Univariable and multivariable Cox proportional hazard regression analysis were performed to identify independent factors associated with CR on ptMRIs.
Between 2013 and 2017, 262 eligible patients were analysed, all treated with Intensity Modulated Radiotherapy (IMRT). Median time from end of RT to the first ptMRI was 93 days (range 32-346). Of the first ptMRIs, 88 (33.2%) were CR, 133 (50.2%) ID, and 44 (16.6%) PR. A second ptMRI was done for 104 (78.2%) of 133 patients with ID status. In this group, 77 (57.9%) of the subsequent MRI were determined to be CR, 21(15.8%) remained ID and 6 (4.5%) PR. T1 tumour stage and AJCC stage I were associated with increased CR rates on first ptMRI on multivariable analysis. ID status was more likely at 75-105 days (3 months +/- 15 days) vs 106-135 days (4 months +/- 15 days) post RT (OR 2.13, 95% CI 1.16-4.12, p = 0.024). LRR developed in 27 (10.1%) patients; 20 (74.1%) were initially detected through MRI, 3 (11.1%) by nasoendoscopy and 2 (7.4%) by PET-CT.
MRI is useful for detecting local recurrence or persistent disease after curative-intent treatment. Most patients will need more than one ptMRI to arrive at a definitive status. The rate of ID ptMRI may be reduced by delaying the first scan to around 4 months post RT.
为了确定根治性放疗后首次磁共振成像(MRI)检查的最佳时间,以及评估 MRI 在局部区域复发(LRR)监测中的作用。
纳入了至少接受过一次治疗后 MRI(ptMRI)检查的根治性治疗的非转移性鼻咽癌(NPC)患者进行分析。回顾性分析 ptMRI 报告,并分为完全缓解(CR)、部分缓解/残留疾病(PR)或不确定(ID)。评估 LRR 患者以确定初始检测是通过 MRI 还是临床手段进行。采用单变量和多变量 Cox 比例风险回归分析确定与 ptMRI 上 CR 相关的独立因素。
2013 年至 2017 年期间,分析了 262 名符合条件的患者,均接受了调强放疗(IMRT)。从放疗结束到首次 ptMRI 的中位时间为 93 天(范围 32-346 天)。首次 ptMRI 中,88 例(33.2%)为 CR,133 例(50.2%)为 ID,44 例(16.6%)为 PR。133 例 ID 状态患者中有 104 例(78.2%)进行了第二次 ptMRI。在这组患者中,77 例(57.9%)随后的 MRI 结果为 CR,21 例(15.8%)仍为 ID,6 例(4.5%)为 PR。多变量分析显示 T1 肿瘤分期和 AJCC I 期与首次 ptMRI 时 CR 率增加相关。在 RT 后 75-105 天(3 个月 +/- 15 天)比 RT 后 106-135 天(4 个月 +/- 15 天)(OR 2.13,95%CI 1.16-4.12,p=0.024)更有可能出现 ID 状态。27 例(10.1%)患者发生 LRR;20 例(74.1%)最初通过 MRI 发现,3 例(11.1%)通过鼻内镜发现,2 例(7.4%)通过 PET-CT 发现。
MRI 可用于检测根治性治疗后局部复发或持续疾病。大多数患者需要进行多次 ptMRI 才能确定明确的状态。通过将首次扫描延迟到放疗后约 4 个月,可以降低 ptMRI 出现 ID 的比例。